Durvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLC
Clinical trial NCT03130764 · WITHDRAWN
Trial details
- NCT number
- NCT03130764
- Sponsor
- Columbia University
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2017-11-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.